Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Lenacapavir, a long-acting HIV capsid inhibitor, is back on track after the Food and Drug Administration lifted a clinical hold on the drug.
The FDA has authorized a new administration method that splits a single Jynneos vial to vaccinate five people.
The engineered protein vaccine was highly effective in a clinical trial but faced a long delay for authorization.
After a long wait, the FDA authorizes Pfizer and Moderna vaccines for children as young as 6 months old.
The injectable antiretroviral could potentially be taken once every six months for HIV treatment or PrEP.
A study found that only 43% of clinical trials reported race and ethnicity. The FDA issued guidance to address these inequalities.
They started on lenacapavir pills and then switched to injections every six months plus an optimized back-ground regimen.
The diagnostic test can provide results in less than three minutes.
Immunocompromised people ages 12 and older are also eligible for an additional shot.
Testing advances made during the COVID-19 pandemic may lead to “test and treat” approaches for hepatitis C. But there’s a holdup.
The FDA says three types of ONE brand condoms, which were launched in 2004, can now be marketed as “safe and effective” for anal sex.
LGBTQ community centers team with the ADVANCE study to research blood donor eligibility and HIV risk. Participants wanted!
Older and immunocompromised people and those with underlying health conditions could benefit most from additional shots.
Some think the U.S. should have had an equivalent of Operation Warp Speed for COVID-19 testing.
Robert Califf headed the Food and Drug Administration for 10 months under Obama. Will he manage to implement his ideas this time around?
Many people who received any of the authorized COVID-19 vaccines are now eligible for an additional dose of their choice.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.